You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CD8

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HNSCC, Melanoma, Gynecologic Cancer Trial in Portland (DP CD8 TIL, DP CD8 TIL KD, Low dose IL-2)

Recruiting
  • HNSCC
  • +5 more
  • DP CD8 TIL
  • +2 more
  • Portland, Oregon
    Providence Portland Medical Center
Jun 5, 2023

Alterations in CD8aß and CD8aa T Cell Levels in Rheumatoid

Not yet recruiting
  • Rheumatoid Arthritis
  • flow cytometry
  • (no location specified)
Apr 12, 2023

Pancreatic Ductal Adenocarcinoma, NSCLC, Colorectal Cancer Trial (AFNT-211)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +4 more
  • (no location specified)
Oct 23, 2023

COL6A3 Positive, HLA-A*0201 Positive Cells Present, PRAME Positive Trial in Houston (biological, drug, procedure)

Active, not recruiting
  • COL6A3 Positive
  • +3 more
  • Aldesleukin
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

CD4/CD8+ Interferon Gamma Release Assay for Monitoring

Active, not recruiting
  • Tuberculosis
  • Interferon gamma release assay (IGRA)
  • Milano, Italy
    IRCCS San Raffaele Scientific Institute
Feb 13, 2023

Ovarian Cancer Trial (Autologous genetically modified ADP-A2M4CD8 cells, Autologous genetically modified ADP-A2M4CD8 cells in

Not yet recruiting
  • Ovarian Cancer
  • Autologous genetically modified ADP-A2M4CD8 cells
  • Autologous genetically modified ADP-A2M4CD8 cells in combination with Nivolumab
  • (no location specified)
Jan 31, 2023

Memory CD8+ T Cells With Sepsis Severity and

Recruiting
  • Sepsis
  • Inflammatory Response
    • Wuhan, Hubei, China
      Department of Critical Care Medicine, Union Hospital, Tongji Med
    May 16, 2023

    MDS, Secondary Acute Myeloid Leukemia Trial in Tampa (CD8 Depleted, Non-engrafting,HLA mismatched unrelated donor lymphocytes,

    Recruiting
    • Myelodysplastic Syndromes
    • Secondary Acute Myeloid Leukemia
    • CD8 Depleted, Non-engrafting,HLA mismatched unrelated donor lymphocytes
    • Standard of Care Chemotherapy
    • Tampa, Florida
      Moffitt Cancer Center
    Sep 27, 2022

    Multiple Sclerosis, Progressive Multifocal Leukoencephalopathy Trial run by the National Institute of Neurological Disorders and

    Not yet recruiting
    • Multiple Sclerosis
    • Progressive Multifocal Leukoencephalopathy
    • 89 Zr-Df-crefmirlimab
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    May 13, 2023

    Immune Markers in Pediatric ITP

    Not yet recruiting
    • ITP - Immune Thrombocytopenia
    • complete blood count, CD3+ , CD4+ , CD8+, CD16+, CD56+, IFN-γ.
    • (no location specified)
    Oct 17, 2023

    HIV-1-infection Trial (FMT capsules, Placebo capsules)

    Not yet recruiting
    • HIV-1-infection
    • FMT capsules
    • Placebo capsules
    • (no location specified)
    Aug 31, 2023

    SARS-CoV-2 Specific CD8 T-Cell Responses to COVID-19 Vaccines in

    Recruiting
    • COVID-19
      • Baltimore, Maryland
      • +1 more
      Feb 2, 2023

      Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Seattle (biological, drug, procedure)

      Completed
      Has Results
      • Recurrent Plasma Cell Myeloma
      • Refractory Plasma Cell Myeloma
      • Autologous Anti-BCMA-CAR-expressing CD4+/CD8+ T-lymphocytes FCARH143
      • +3 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Aug 3, 2022

      Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

      Suspended
      • Juvenile Myelomonocytic Leukemia
      • +27 more
      • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
      • +2 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Jan 11, 2023

      CD8+ T-cell PET/CT Imaging in COVID-19 Patients

      Recruiting
      • Lymphopenia Due to COVID-19
      • +2 more
      • [89Zr]Df-IAB22M2C PET/CT scan
      • Nijmegen, Gelderland, Netherlands
        Radboud university medical center
      Jun 2, 2022

      SARS-CoV-2 Specific CD8 T Cells in Humans

      Recruiting
      • COVID-19
        • Baltimore, Maryland
          National Institute of Aging, Clinical Research Unit
        Jul 6, 2022

        NSCLC, Small Cell Lung Cancer, Pancreas Cancer Trial in Shanghai (Infusion of iNKT cells and CD8+T cells)

        Active, not recruiting
        • Non-small Cell Lung Cancer
        • +5 more
        • Infusion of iNKT cells and CD8+T cells
        • Shanghai, Shanghai, China
          Shanghai Public Health Clinical Center
        May 6, 2022

        Health Status of Children Born After Assisted Reproductive

        Recruiting
        • Children Born After Assisted Reproductive Technologies
        • +2 more
        • hemogram examination
        • Almaty, Kazakhstan
          Sevara ilmuratova
        Oct 17, 2023

        Advanced Gastric Carcinoma, CD8+ Tumor Infiltrating Lymphocytes, Neoadjuvant Immunotherapy Trial (radical surgery after

        Not yet recruiting
        • Advanced Gastric Carcinoma
        • +2 more
        • radical surgery after neoadjuvant immunotherapy
        • radical surgery after neoadjuvant chemotherapy
        • (no location specified)
        Feb 26, 2022

        Melanoma, Melanoma Stage III Trial in New York (diagnostic test, drug, procedure)

        Recruiting
        • Melanoma
        • Melanoma Stage III
        • PET Scan
        • +3 more
        • New York, New York
          Memorial Sloan Kettering Cancer Center (All Protocol Activities)
        Jun 24, 2022

        Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma Trial in Houston (Aldesleukin, Autologous CD8+

        Active, not recruiting
        • Metastatic Malignant Neoplasm in the Liver
        • Metastatic Uveal Melanoma
        • Aldesleukin
        • +3 more
        • Houston, Texas
          M D Anderson Cancer Center
        Jan 20, 2023

        Melanoma (Skin) Trial in Philadelphia (89Zr-Df-IAB22M2C PET/CT)

        Enrolling by invitation
        • Melanoma (Skin)
        • 89Zr-Df-IAB22M2C PET/CT
        • Philadelphia, Pennsylvania
          Perleman Center for Advanced Medicine
        May 31, 2022

        Melanoma, Renal Cell Carcinoma Trial in Hull (Zirconium 89Zr crefmirlimab berdoxam)

        Recruiting
        • Melanoma
        • Renal Cell Carcinoma
        • Zirconium 89Zr crefmirlimab berdoxam
        • Hull, United Kingdom
          Castle Hill Hospital
        Feb 15, 2023

        Metastatic Cancer, Unresectable Malignant Tumor Trial in Groningen (Anti-CD8 PET imaging agent)

        Recruiting
        • Metastatic Cancer
        • Unresectable Malignant Neoplasm
        • Anti-CD8 PET imaging agent
        • Groningen, Netherlands
          University Medical Center Groningen
        Mar 1, 2022

        Metastatic Malignant Solid Tumor Trial in Duarte (procedure, radiation, drug)

        Recruiting
        • Metastatic Malignant Solid Neoplasm
        • Lymphoma
        • Positron Emission Tomography
        • +3 more
        • Duarte, California
          City of Hope Medical Center
        Nov 18, 2022